ImageneBio, Inc.
IMA
$4.04+0.25%
End of day · as of Oct 17, 2026, 4:00 AM ET
Mkt cap
$64.74M
EV/Sales
-37.24
P/E ratio
N/A
FY2025 Revenue
$800,000
EPS (TTM)
$-10.92
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-5668.63%
Beta
N/A
Div yield
N/A
Sector
Healthcare
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Latest reported IMA revenue for 2025-12-31 was $800.0K. Net income was -$45.3M. Revenue was down 77.1% from 2024-12-31 to 2025-12-31. IMA currently screens at market cap $64.7M.
Use this IMA research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full IMA income, balance, and cash tables.
ImageneBio, Inc. (IMA) is a biotechnology company in the Healthcare sector.
Latest cached ImageneBio, Inc. (IMA) revenue for Dec 31, 2025 was $800.0K. Net income was -$45.3M. Statements: https://lician.com/financials/ima
ImageneBio, Inc. (IMA) market capitalization is $64.7M on the latest cached snapshot.
ImageneBio, Inc. (IMA) cached previous close $4.03; day range $4.00 – $4.15; volume 9,654. Session quote: https://lician.com/quote/ima
ImageneBio, Inc. (IMA) latest cached earnings event is "IMA earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached IMA filing is 8-K · Aug 5, 2026. Filings: https://lician.com/sec/ima